General Information of the Compound
| Compound ID |
CP0208716
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[2-(6-Methoxy-1,3,3a,4,5,9b-hexahydro-benzo[e]isoindol-2-yl)-ethyl]-8-methyl-1H-benzo[4,5]thieno[3,2-d]pyrimidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H27N3O3S
|
||||||||||||||||||
| Molecular Weight |
461.587
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc2[C@@H]3CN(CCn4c(=O)[nH]c5c6cc(C)ccc6sc5c4=O)C[C@@H]3CCc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H27N3O3S/c1-15-6-9-22-19(12-15)23-24(33-22)25(30)29(26(31)27-23)11-10-28-13-16-7-8-18-17(20(16)14-28)4-3-5-21(18)32-2/h3-6,9,12,16,20H,7-8,10-11,13-14H2,1-2H3,(H,27,31)/t16-,20+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZVEGISGGPKQZEM-OXJNMPFZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01849, Alpha-1B adrenergic receptor
Protein ID: PT02075, Alpha-1D adrenergic receptor